Mark B Hamner MD
Geriatric Psychiatry
Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina College of Medicine
Join to view full profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Fax+1 843-937-6110
Dr. Hamner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Hamner is a psychiatrist based in Charleston, SC, with training from the University of North Carolina Hospitals. Since completing his medical education at the University of North Carolina at Chapel Hill School of Medicine in 1982, he has contributed to the field through both research and clinical trials. His research work includes publications on treatments for post-traumatic stress disorder (PTSD), cognitive impairment in veterans, and PTSD with secondary psychotic features, with several of his publications being cited multiple times. Dr. Hamner has been involved in numerous clinical trials investigating treatments for mood disorders and schizophrenia, in addition to PTSD.
Education & Training
University of North Carolina HospitalsResidency, Psychiatry, 1982 - 1986
University of North Carolina at Chapel Hill School of MedicineClass of 1982
Certifications & Licensure
SC State Medical License 1991 - 2027
GA State Medical License 1986 - 2009
NC State Medical License 1985 - 1999
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
- Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD) Start of enrollment: 2003 Aug 01
- Quetiapine Augmentation for Treatment-resistant PTSD Start of enrollment: 2006 Jan 01
- Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD) Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 8 citationsA Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.Michael A Norred, Zachary D Zuschlag, Mark B Hamner
Drugs. 2024-02-01 - Post-traumatic stress disorder: the role of the amygdala and potential therapeutic interventions - a review.Lori L Davis, Mark B Hamner
Frontiers in Psychiatry. 2024-01-01 - 6 citationsA Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans.Sudie E Back, Julianne C Flanagan, Jim Mintz, Kathleen T Brady, Jennifer Jones
The Journal of Clinical Psychiatry. 2023-03-08
Press Mentions
- Exploring Psychopharmacology for PTSD & More Latest News HereAugust 14th, 2022
Grant Support
- Synthesis and Optimization of the Aleutianamine Class of AlkaloidsMEDICAL UNIVERSITY OF SOUTH CAROLINA2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
